I have no problem with them taking some credit. If I recall correctly, they reached out to CYDY, not the other way around, so they earned the right to promote themselves. My response was regarding "increased coverage" of CYDY, and I didn't see that article as covering CYDY, but rather promoting Montifiore. Don't get me wrong, I wish there were 20 other research hospitals also promoting their participation in treatments using Leronlimab.